We are excited to announce that today after 2 years of hard work we submitted to the Food and Drug Administration two Investigational Device Exemptions (IDE) for our wireless vagus nerve stimulator called ReStore. This implantable biomedical device, entirely developed at The University of Texas at Dallas will allow us to perform clinical trials using Targeted Plasticity Therapy to restore functions lost as a result of neurological injuries and disease. These IDEs will be used in our funded PTSD and Spinal Cord Injury clinical trials. We expect to submit additional IDEs for clinical trials in Tinnitus and Stroke later this year.

This was an enormous undertaking that involved all members of the TxBDC team and countless hours of hard work. We are now positioned to change the world because of your efforts. Thank you to everyone for all that you do.